Copyright
©The Author(s) 2025.
World J Hepatol. Aug 27, 2025; 17(8): 108333
Published online Aug 27, 2025. doi: 10.4254/wjh.v17.i8.108333
Published online Aug 27, 2025. doi: 10.4254/wjh.v17.i8.108333
Table 1 General information of the normal and abnormal groups, n (%)
Parameter | Normal group (n = 3553) | Abnormal group (n = 167) | Statistic | P value |
Gender, male | 1037 (29.19) | 88 (52.69) | χ² = 41.78 | < 0.01 |
Age, year | 56.00 (47.00, 66.00) | 59.00 (50.00, 67.00) | Z = -1.51 | 0.13 |
Weight, kg | 58.00 (52.00, 65.00) | 59.00 (52.35, 66.50) | Z = -0.93 | 0.35 |
BMI, kg/m2 | 22.89 (20.62, 25.33) | 22.66 (20.37, 25.56) | Z = -0.31 | 0.76 |
Past medical history | ||||
High blood pressure | 1126 (31.69) | 51 (30.54) | χ² = 0.10 | 0.75 |
Diabetes | 2487 (70.00) | 116 (69.46) | χ² = 0.02 | 0.88 |
Coronary heart disease | 1480 (41.65) | 72 (43.11) | χ² = 0.14 | 0.71 |
Cerebral infarction | 90 (2.53) | 2 (1.20) | χ² = 0.69 | 0.41 |
Viral hepatitis | 211 (5.94) | 13 (7.78) | χ² = 0.96 | 0.33 |
Chronic hepatitis | 17 (0.48) | 1 (0.60) | - | 0.56 |
Liver cirrhosis | 12 (0.34) | 0 (0.00) | - | 1.00 |
Hyperlipidemia | 140 (3.94) | 10 (5.99) | χ² = 1.73 | 0.19 |
COPD | 11 (0.31) | 1 (0.60) | - | 0.42 |
Chronic kidney disease | 91 (2.56) | 6 (3.59) | χ² = 0.32 | 0.57 |
Table 2 Results of laboratory testing analysis in the normal and abnormal groups
Parameter, unit | Normal group (n = 3553) | Abnormal group (n = 167) | Statistic | P value |
AST, U/L | 18.00 (15.00, 22.00) | 30.00 (20.00, 52.00) | Z = -12.42 | < 0.01 |
ALT, U/L | 15.00 (11.00, 21.00) | 29.00 (17.00, 69.00) | Z = -10.83 | < 0.01 |
ALP, g/L | 70.00 (57.00, 87.00) | 78.00 (63.64, 111.00) | Z = -4.78 | < 0.01 |
GGT, U/L | 19.00 (14.00, 30.00) | 38.00 (21.00, 82.50) | Z = -9.77 | < 0.01 |
Tbil, μmol/L | 8.60 (6.00, 12.10) | 10.30 (7.10, 15.60) | Z = -4.23 | < 0.01 |
Total protein, g/L | 71.30 (68.80, 74.60) | 70.90 (67.05, 72.70) | Z = -3.35 | < 0.01 |
Albumin, g/L | 42.90 (40.20, 45.50) | 41.50 (38.20, 44.45) | Z = -4.23 | < 0.01 |
Globulin, g/L | 27.20 (25.70, 30.40) | 27.20 (25.50, 30.60) | Z = -0.45 | 0.65 |
Glu, mmol/L | 5.31 (4.78, 6.36) | 5.77 (5.00, 6.88) | Z = -3.11 | < 0.01 |
HB, g/L | 125.00 (109.00, 136.00) | 125.00 (106.50, 140.50) | Z = -0.90 | 0.37 |
WBC, × 109/L | 6.35 (5.27, 7.72) | 6.37 (5.30, 7.94) | Z = -0.53 | 0.60 |
N, × 109/L | 3.94 (3.07, 5.08) | 3.92 (2.90, 5.13) | Z = -0.28 | 0.78 |
RBC, × 1012/L | 4.33 (3.95, 4.68) | 4.26 (3.74, 4.68) | Z = -1.85 | 0.06 |
PLT, × 1012/L | 259.00 (215.00, 314.00) | 232.00 (178.00, 278.00) | Z = -4.72 | < 0.01 |
K+ , mmol/L | 4.00 (3.80, 4.20) | 4.01 (3.77, 4.21) | Z = -0.14 | 0.89 |
Na+ , mmol/L | 140.00 (139.00, 142.00) | 140.00 (139.00, 142.00) | Z = -1.20 | 0.23 |
Ca2+ , mmol/L | 2.30 (2.30, 2.30) | 2.30 (2.30, 2.30) | Z = -0.05 | 0.96 |
CL- , mmol/L | 103.80 (102.10, 105.50) | 103.70 (101.60, 105.40) | Z = -0.86 | 0.39 |
TC, mmol/L | 4.71 (4.49, 4.91) | 4.71 (4.46, 4.75) | Z = -0.42 | 0.67 |
Tg, mmol/L | 1.35 (1.19, 1.45) | 1.35 (1.29, 1.60) | Z = -1.29 | 0.20 |
LDL, mmol/L | 3.06 (2.87, 3.20) | 3.06 (2.79, 3.06) | Z = -1.14 | 0.25 |
HDL, mmol/L | 1.18 (1.14, 1.26) | 1.18 (0.99, 1.18) | Z = -2.96 | < 0.01 |
Uric, mmol/L | 350.00 (350.00, 350.00) | 350.00 (350.00, 350.00) | Z = -0.74 | 0.46 |
EGFR, mmol/L | 94.75 (81.14, 106.41) | 93.72 (83.34, 104.34) | Z = -0.20 | 0.84 |
Urea, mmol/L | 4.68 (3.72, 5.75) | 4.81 (3.91, 5.81) | Z = -0.97 | 0.33 |
Cr, mmol/L | 65.00 (56.00, 78.00) | 69.00 (58.00, 83.00) | Z = -1.98 | 0.05 |
Table 3 Intraoperative data analysis for the normal and abnormal groups
Parameter | Normal group (n = 3553) | Abnormal group (n = 167) | Statistic | P value |
Head and neck surgery | 14 (0.39) | 3 (1.80) | - | 0.04 |
Operation on the spine and limbs | 643 (18.10) | 42 (25.15) | χ² = 5.28 | 0.02 |
Operation on the esophagus, gastrointestinal tract, pancreas, spleen, and appendix | 907 (25.53) | 88 (52.69) | χ² = 60.08 | < .01 |
Operation on the kidneys, bladder, and ureter | 218 (6.14) | 8 (4.79) | χ² = 0.51 | 0.48 |
Operation on the uterus, ovaries, and fallopian tube | 1771 (49.85) | 26 (15.57) | χ² = 75.04 | < 0.01 |
Time of operation | 239.00 (205.00, 288.00) | 290.00 (232.00, 359.00) | Z = -7.16 | < 0.01 |
Anesthesia time, minute | 295.00 (257.00, 346.00) | 352.00 (290.00, 417.00) | Z = -7.50 | < 0.01 |
Length of hospital stay, day | 13.00 (9.00, 18.00) | 16.00 (11.00, 22.00) | Z = -5.24 | < 0.01 |
ASA rating | ||||
I | 169 (4.76) | 5 (2.99) | χ² = 1.11 | 0.29 |
II | 2709 (76.25) | 115 (68.86) | χ² = 4.76 | 0.03 |
III | 671 (18.89) | 45 (26.95) | χ² = 6.67 | < 0.01 |
IV | 4 (0.11) | 2 (1.20) | - | 0.03 |
Sufentanil, μg | 10.00 (5.00, 15.00) | 10.00 (5.00, 15.00) | Z = -1.31 | 0.19 |
Whether to pump remifentanil | 3131 (88.12) | 164 (98.20) | χ² = 16.02 | < 0.01 |
Rocuronium, mg | 2.49 ± 10.76 | 2.94 ± 10.66 | t = -0.53 | 0.59 |
Etomidate, mg | 6.88 ± 16.13 | 8.70 ± 19.38 | t = -1.41 | 0.16 |
Whether to pump propofol | 2681 (75.46) | 119 (71.26) | χ² = 1.51 | 0.22 |
Dosage of intravenous propofol, mg | 35.40 ± 153.54 | 30.48 ± 107.01 | t = 0.41 | 0.68 |
Dexmedetomidine, μg | 4.09 ± 12.96 | 3.92 ± 13.37 | t = 0.17 | 0.87 |
Sevoflurane, mL | 60.00 (40.00, 100.00) | 80.00 (50.00, 120.00) | Z = -4.29 | < 0.01 |
Table 4 Results of the logistic regression analysis
Parameter | β | Se | Wald χ2 | P value | Or | Lower limit of 95%CI | 95%CI upper bound |
Age, year | -0.011 | 0.007 | 2.018 | 0.155 | 0.989 | 0.975 | 1.004 |
Sex, male | -0.043 | 0.227 | 0.035 | 0.851 | 0.958 | 0.614 | 1.495 |
Anesthesia time, minute | 0.005 | 0.001 | 25.564 | 0 | 1.005 | 1.003 | 1.007 |
ASA II | -0.027 | 0.215 | 0.016 | 0.899 | 0.973 | 0.638 | 1.483 |
Whether to pump remifentanil | 1.528 | 0.623 | 6.023 | 0.014 | 4.610 | 1.360 | 15.624 |
Cr, mmol/L | -0.002 | 0.003 | 0.508 | 0.476 | 0.998 | 0.992 | 1.004 |
Sufentanil | 0.008 | 0.002 | 16.397 | 0.00 | 1.008 | 1.004 | 1.012 |
AST, U/L | 0.042 | 0.009 | 21.633 | 0.00 | 1.043 | 1.025 | 1.062 |
ALT, U/L | 0.019 | 0.006 | 9.411 | 0.002 | 1.019 | 1.007 | 1.031 |
ALP, g/L | -0.002 | 0.002 | 0.371 | 0.543 | 0.998 | 0.994 | 1.003 |
GGT, U/L | 0.003 | 0.002 | 3.397 | 0.065 | 1.003 | 1.00 | 1.007 |
TBIL, μmol/L | 0.015 | 0.011 | 1.907 | 0.167 | 1.015 | 0.994 | 1.037 |
Albumin, g/L | -0.013 | 0.021 | 0.385 | 0.535 | 0.987 | 0.946 | 1.029 |
PLT, × 1012/L | -0.004 | 0.001 | 10.624 | 0.001 | 0.996 | 0.994 | 0.999 |
Glu, mmol/L | 0.011 | 0.041 | 0.078 | 0.78 | 1.012 | 0.934 | 1.096 |
Length of hospital stay, day | 0.014 | 0.008 | 3.37 | 1 | 0.066 | 1.014 | 0.999 |
Operation on the esophagus, gastrointestinal tract, pancreas, spleen, and appendix | 0.824 | 0.229 | 12.988 | 0.00 | 2.279 | 1.456 | 3.567 |
Operation on the uterus, ovaries, and fallopian tube | -0.773 | 0.310 | 6.231 | 0.013 | 0.461 | 0.251 | 0.847 |
Constant | -6.847 | 1.46 | 22.009 | 0.00 | 0.001 |
- Citation: Zhong L, Wang HY, Li XN, Ling Q, Hao N, Li XY, Zhao GF, Liao M. Risk factors and predictive modeling of early postoperative liver function abnormalities. World J Hepatol 2025; 17(8): 108333
- URL: https://www.wjgnet.com/1948-5182/full/v17/i8/108333.htm
- DOI: https://dx.doi.org/10.4254/wjh.v17.i8.108333